Concepedia

Author

M. Colledan

Ospedale Papa Giovanni XXIIIORCID

Also Known As

A Camillo’, Amilcare Parisi, Antonino Castellaneta, Colledan M, Colledan, M., Colledan, Michele, D F Altomare, Domenico Pinelli, Ettore Colangelo, F Bozzetti

452

Publications

8.4K

Citations

47

H-Index

102

Concepts

All Affiliations

Ospedale Papa Giovanni XXIIIUniversity of PaduaIstituto Mediterraneo per i Trapianti e Terapie ad Alta SpecializzazioneFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoUniversity of Milan
MC

About

M. Colledan is an author at Ospedale Papa Giovanni XXIII specializing in medicine, liver transplantation, and hepatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

28

56

2.6K

2

Public Health

5

6

299

3

Health Sciences

3

3

91

4

Biostatistics

2

3

150

5

Blood Transplantation

1

1

72

M. Colledan

×

109

Publications

6.3K

Citations

43

H-Index

YearCitations

2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation

René Adam, Vincent Karam, Valérie Cailliez,

Transplant International

2018

465

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

Edward K. Geissler, Andreas A. Schnitzbauer, C. Zülke,

Transplantation

2015

409

Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial

Vincenzo Mazzaferro, Davide Citterio, Sherrie Bhoori,

The Lancet Oncology

2020

314

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa,

The Lancet Oncology

2021

280

Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC

Andrea Notarpaolo, Richard Layese, Paolo Magistri,

Journal of Hepatology

2016

216

Platelet-Derived Growth Factor-D And Rho Gtpases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma

Massimiliano Cadamuro, Giorgia Nardo, Stefano Indraccolo,

Hepatology

2013

166

Patterns of hepatitis delta virus reinfection and disease in liver transplantation

A. Ottobrelli, Alfredo Marzano, Antonina Smedile,

Gastroenterology

1991

159

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

Andreas A. Schnitzbauer, Carl Zuelke, Christian Graeb,

BMC Cancer

2010

159

Analysis of Liver Repair Mechanisms in Alagille Syndrome and Biliary Atresia Reveals a Role for Notch Signaling

Luca Fabris, Massimiliano Cadamuro, Maria Guido,

American Journal Of Pathology

2007

137

mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

Andreas A. Schnitzbauer, Natalie Filmann, René Adam,

Annals of Surgery

2020

133

Page 1